Publication | Closed Access

Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine

Tumor ImmunologyProtein VaccineMedicineMelanomaImmunologyPd1/pdl1 BlockadeTherapeutic VaccineImmune Checkpoint InhibitorImmunotherapyB16 MelanomaRadiation Oncology